#5 - Dr Reid Robison: Undoing Rigid Thinking

Reid Robison, MD MBA, is a psychedelic psychiatrist & researcher who has led over 100 clinical trials in neuropsychiatry. He completed his undergraduate in Neuroscience at Brigham Young University and went on to medical school at the University of Utah where he earned both his MD and MBA. . Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad and is the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders.
Reid Robison, MD MBA, is a psychedelic psychiatrist & researcher who has led over 100 clinical trials in neuropsychiatry. He completed his undergraduate in Neuroscience at Brigham Young University and went on to medical school at the University of Utah where he earned both his MD and MBA. Of course, he didn’t stop there, after residency training in Psychiatry, Dr Robison completed fellowship training in Neurodevelopmental Genetics, followed by a postdoc in Bioinformatics. 


As an early adopter and researcher of Ketamine in psychiatry, Reid obtained his first grant to study ketamine in 2011. He also led the Utah site for the pivotal ketamine study for TRMDD by Janssen, leading up to the company’s recent FDA-approval of Spravato. To date, Reid has guided thousands of ketamine therapy journeys and hundreds of Spravato dosing sessions. 


Reid has built a number of therapeutic-driven companies including Tute Genomics, a venture-backed personalized medicine startup that was acquired in 2016, Cedar Psychiatry, which he co founded and serves as a Medical Director of Center for Change, a top Eating Disorder program. He is also a founding board member at the Utah-based non-profit organisation Psychedelic Institute. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad, and is the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders.




Tommy Moore